ResMed Valuation
Is RMD * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of RMD * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: RMD * (MX$3040) is trading above our estimate of fair value (MX$2897.03)
Significantly Below Fair Value: RMD * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for RMD *?
Other financial metrics that can be useful for relative valuation.
What is RMD *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$32.07b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 7.2x |
Enterprise Value/EBITDA | 22.9x |
PEG Ratio | 2.5x |
Price to Earnings Ratio vs Peers
How does RMD *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 51.1x | ||
4543 Terumo | 36.8x | 12.0% | JP¥4.0t |
STE STERIS | 41.3x | 15.8% | US$22.8b |
IDXX IDEXX Laboratories | 49.4x | 9.9% | US$43.8b |
STMN Straumann Holding | 76.8x | 21.0% | CHF18.9b |
RMD * ResMed | 33.5x | 13.1% | Mex$32.1b |
Price-To-Earnings vs Peers: RMD * is good value based on its Price-To-Earnings Ratio (33.5x) compared to the peer average (51.1x).
Price to Earnings Ratio vs Industry
How does RMD *'s PE Ratio compare vs other companies in the Global Medical Equipment Industry?
Price-To-Earnings vs Industry: RMD * is expensive based on its Price-To-Earnings Ratio (33.5x) compared to the Global Medical Equipment industry average (28x).
Price to Earnings Ratio vs Fair Ratio
What is RMD *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 33.5x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate RMD *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.